Cairo – Mubasher: The extraordinary general meeting (EGM) of GlaxoSmithKline (GSK Egypt) has approved to sell intangible and movable consumer healthcare assets, excluding real estate and machinery.
The independent financial advisor Grant Thornton - Egypt, has valued the assets at EGP 1.179 billion, according to a bourse filing on Sunday.
It is noteworthy to mention that in October 2021, the company's board approved a fair value (FV) report prepared by the independent financial advisor for the consumer health business assets.
